Download PDFPDF

1447 A 30 PDX panel of 3D in vitro tumor models identifies responders to pembrolizumab and solitomab
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address